Influenza- Prevention & Therapy

Send us Fan MailIn this episode, we take a deep dive into the clinical management of influenza, a viral respiratory infection that causes significant morbidity and mortality globally and in Australia every year. We explore why the routine annual flu vaccine remains our most critical intervention, and break down the circulating subtypes, including Influenza A (H1N1 and H3N2) and Influenza B.Join us as we unpack the evolution of flu vaccines, explaining the shift from trivalent to quadrivalent formulations to improve protection. We also highlight targeted vaccine strategies for high-risk demographics, such as the safety and necessity of vaccinating pregnant women at any stage of pregnancy, and the introduction of high-dose and adjuvanted vaccines specifically designed to trigger a stronger immune response in adults over 65.Finally, we navigate the complex role of antiviral drugs, primarily Neuraminidase Inhibitors (NAIs) like Oseltamivir and Zanamivir. We discuss the crucial 48-hour window for treatment, how these medications impact symptom duration and mortality, and why they should never be viewed as a substitute for vaccination. We wrap up with a look at the limitations of current antiviral prophylaxis and what novel therapies are on the horizon to combat emerging viral resistance.Key Takeaways in this Episode:The Power of Prevention: Why routine vaccination is the most important defense against severe flu complications.Vaccine Innovations: Understanding the differences between standard quadrivalent vaccines and specialized high-dose or adjuvanted trivalent vaccines for older adults.Antiviral Realities: How NAIs work, who needs them most, and their modest effects on symptom duration.Outbreak Management: The role of post-exposure prophylaxis in high-risk households and residential care facilities.Support the show⚠️ Disclaimer: The voices in this podcast are AI-generated. This content is produced for entertainment and learning purposes only and does not constitute medical advice. Clinical decisions should always be made in accordance with current guidelines, individual patient circumstances, and in consultation with appropriate colleagues and specialists.